https://www.selleckchem.com/pr....oducts/Perifosine.ht
8%). Overall, both confidence and comfort level working with residents who were at risk, confirmed, or suspected of having COVID-19 increased after participating in the ECHO sessions (effect sizes≥0.7, Wilcoxon signed rank P.001). Participants also reported impact on intent to change behavior, resident care, and knowledge sharing. The results demonstrate that ECHO COE-LTC COVID 19 effectively delivered time-sensitive information and best practices to support LTC teams and residents. It may be a critical platform during this pande